section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Tested in sterile water for injection.

d Tested in Ringer’s injection, lactated.

e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

f Concentration unspecified.

g Concentration of fosphenytoin expressed in milligrams of phenytoin sodium equivalents (PE) per mL.

h Given over three minutes into a heparin infusion run at 1 mL/min.

i Tested in dextrose 5% in sodium chloride 0.225%.

j Test performed using the formulation WITHOUT edetate disodium.

k Amoxicillin component. Amoxicillin in a 10:1 fixed-ratio concentration with clavulanic acid.

l Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

m Not specified whether concentration refers to single component or combined components.

n Tested in both dextrose 5% and sodium chloride 0.9%.

o Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

p Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

q Test performed using the formulation WITH edetate disodium.

r As midazolam base rather than the salt.

s Salt not specified.

t Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

u Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.